Extra Uterine Growth RestrictionNCT06731439
Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
A study testing Starting feeds within 6 hours of life and Standard feeding protocol in people with Extra Uterine Growth Restriction and Premature Infant Disease, run by University of Tennessee at 1 site in United States.
Trial summary
Feeding advancements in ELBW infants have evolved over decades. The fear of causing mortality and morbidity, notably NEC, have made providers cautious when advancing feeds. ELBW infants initially remained NPO for several days before initiating trophic feeds. Read more about this study
- Who is it for?
- Ages 1 minute to 6 hours
- Conditions the study is for
- Extra Uterine Growth Restriction, Premature Infant Disease, VLBW - Very Low Birth Weight Infant
- What is being tested?
- Starting feeds within 6 hours of life and Standard feeding protocol
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 248 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jun 2024to 30 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 minute to 6 hours
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- All infants less than or equal to 1000 g
- Clinical care team in agreement with patient's participation
- All mothers with pregnancies with EFW close to 1000g or less.
Who cannot join
- 1 congenital malformations that may affect gastro intestinal perfusion
- 2 Clinically progressing towards imminent death
- 3 congenital gastrointestinal obstructions
- 4 Mothers unlikely to deliver infants ≤ 1000g
- 5 Infant on pressors other than dopamine given at < 5mcg/kg/min. Dopamine is an exclusion if administered at a dose exceeding 5mcg/kg/min.
- 6 Mothers who are not in a sound mental state to be consented either to their critical condition, intubated, sedated, for examples
- 7 Mothers who are critically ill where by it is felt that mom will not be able to participate in the consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Regional One Health
Memphis, Tennessee, 38163
Mohamad Elabiad, MD, 9014484751, Melabiad@uthsc.edu
Ihinosen Edgal, MD, 9014484750, iedgal@uthsc.edu
About this study
Feeding advancements in ELBW infants have evolved over decades. The fear of causing mortality and morbidity, notably NEC, have made providers cautious when advancing feeds. ELBW infants initially remained NPO for several days before initiating trophic feeds. However, data then showed that there was no increase in mortality and morbidity if trophic feeds were initiated earlier. Then data showed that a short duration of trophic feeds did not increase mortality and morbidity when compared to a prolonged duration. More recent data showed that enteral feeding should be initiated early, preferably within 24 hours of birth, because it may promote feeding tolerance, shorten the time to reach total enteral feeding, and reduce the incidence of extrauterine growth restriction and late onset sepsis without increasing the risk of developing NEC. The management of enteral nutrition in ELBW infants is still very variable. For example, there is no consensus on the optimal time point after birth at which enteral nutrition can be started. This study evaluates the benefits of starting feeds by 6 hours of life Purpose: The primary aim of this study is to evaluate if in infants ≤ 1000g birth weight, is there a benefit initiating feeds by 6 hours of life (compared to current feeding practice data of 3 days of life) on decreasing the time to attain full feeds in the first 30 days of life. The secondary aim is to evaluate if antenatal feeding discussions would streamline feeding management post-delivery.
Read the detailed description
Rationale: Although current evidence supports initiating enteral feedings as early as the first day of life in extremely low birth weight infants, there are two main barriers that are usually associated with the initiation of feeding not taking place until an average of the third day of life. Since it is common to supplement the infant's nutrition with donor breast milk, and since donor breast milk requires parental consent, the process of consenting is usually done after the infant is born. This would be the time when the parents are updated with the status of their child and the time when other consents are taken. For example, this would be the time to talk about and take consent for blood transfusions, central line placement, and donor breast milk supplementing the infant's nutrition. The mother is the one most commonly giving consent. In situations after cesarean section or after receiving pain medications, the mother is not in a state where she can be approached for consent. This is typically not an issue for interventions like blood transfusions and central line insertions as the need does not arise typically until after a few days. However, when it comes to enteral feeding, it is recommended to start feeding as early as possible. However, because of the previously listed reasons, this sometimes gets pushed further until the mother is in a more stable situation to approach her for consent.
Another important aspect of feeding pertains to what is considered feeding and what is considered gut priming. It is generally considered that enteral feedings of 10 ml/kg/day are not enough volume to be considered "feeding." This volume is considered more of gut priming that stimulates gut enzymes to get produced and starts the clock for the eventual advancement of feeds. For these initial 10 ml/kg/day volume feeds, the term minimal enteral nutrition has been commonly used. In patients to be enrolled in this study, this will come out to be an average of 0.75 ml every 3 hours, a volume that is typically less than the volume of gastric juice being internally produced by the infant. It is also a volume so small that it is not thought to lead to any significant negative sequelae.
On the other hand, research has shown that prolonged enteral fasting may diminish the functional adaptation of the immature gastrointestinal tract and extend the need for parenteral nutrition along with its risk of sepsis-related morbidity and mortality. Research has also shown that the initiation of early enteral feeds could release trophic endogenous agents and inhibit the release of inflammatory mediators and cytokines. It also assists with the development of the intestinal mucosa, activates digestive enzymes, and improves digestion and absorption to avoid the complications associated with vascular catheterization, sepsis, long-term fasting, and vascular alimentation.
There are no uniform guidelines of how fast to advance feeds in this premature infant population. Depending on the practice, it may take a premature infant 7-15 days to reach the 150 ml/kg/day target volume.
Starting feeds by 6 hours is expected to initiate the feeding process for premature infants and be associated with several benefits. The aim of this study is to investigate if finalizing nutritional care plans with the mother antenatally offers any clinically beneficial outcomes in either streamlining the nutritional care plan as a short-term outcome or being associated with beneficial long-term outcomes. This is currently not practiced because either there is not enough personnel or it is felt not of a high yield because the mother may not end up delivering and come back at another visit to deliver. The study would leverage that starting feeds by 6 hours of life is not considered unsafe because the volume of milk that would be given every 3 hours is \<1ml. However, starting early would have helped the infant start the feeding advancement process. The focus is more on "starting" than on "feeding" since the volume received in the first 24 hours is not considered food as much as it is considered gut priming. In other words, the treatment arm group that will have their feeds started by 6 hours of age will have the benefit of having their nutrition clock started earlier when compared to the current standard of care.
Study Project Population:
Infants will be eligible for the study if they have a birth weight ≤1000g and are born in the Regional One Health neonatal intensive care unit in Memphis, TN, during study enrollment. In addition, the clinical care team at the time of enrollment must agree with the neonate\'s participation. Infants found to have congenital malformations, congenital gastrointestinal obstructions, on more than one pressor, or on dopamine \> 5 mcg/kg/min will be excluded. Infants clinically progressing towards imminent death will also be excluded. The mothers of these infants will also be included as part of the study population as the investigators will be collecting maternal health information as it directly affects the neonates.
Research Design:
This will be a prospective randomized controlled trial. The study will be unblinded and conducted at Regional One Health. The target population will be infants with a birth weight of ≤1000g. After informed consent is obtained from parents and after birth but before 6 hours of life, infants meeting the criteria will be randomized to one of two arms: early feeding (intervention group) or standard protocol feeding (control group). In the intervention group, feeds of expressed breast milk, donor breast milk, or formula will be initiated within 6 hours of life based on the mother\'s feeding preference obtained during the antenatal consent. Feeds will be advanced daily (10 ml/kg/day in the \<750g birth weight group and 15 ml/kg/day in the 751-1000g birth weight group) and managed by the primary care team based on their assessment. In the control group, the primary care team will start feedings based on the current protocol. This includes not advancing for the first three days after feeding initiation for infants weighing \< 750g per current feeding protocol. If randomized to the control group, all feeding management initiation, advancement, and obtaining consent for donor breast milk will be done by the primary care team. This step is important as it helps to evaluate if antenatal feeding discussions would streamline feeding management post-delivery.
Study Project/Procedure: The growth indices , including height (cm), weight (g), head circumference (cm), and calculated BMI (kg/m2), will be performed weekly as part of our unit\'s standard practice for all infants admitted. Patient data will be collected from medical records at regular intervals during the study. The primary medical team will manage all medical and feeding-related decisions. The maternal data that the investigators will be collecting for this study from the mother\'s chart is information such as age, BMI, medications used during pregnancy, medical problems such as diabetes or high blood pressure, and other information that could directly influence the neonate. Milk fortification will take place when feeding volumes reach 40 ml/kg/d. All patients will have feedings temporarily stopped during blood transfusions as per unit guidelines. The primary team can decide on feeding advancement if they plan to administer more than 48 hours of antibiotics. The volume used to start the feeding is not large enough to likely be associated with any feeding intolerance. In both the treatment and control groups, if the primary team decides that the infant is not tolerating feeding, then standard clinical interventions are applicable. These could range from decreasing the volume of feeding to a lower volume or even stopping the feeds completely. Feeding intolerance is not uncommon in this population and both interventions of either decreasing the volume or stopping the feeding are also common interventions. If feeding advancements are paused or feedings are stopped altogether, the primary team will be asked to document their concerns and reasons why feedings are paused or stopped. This will be evaluated every 12 hours.
At a Power=80%, α=5%, and to detect a mean difference of 4(±5) days between the early feeding intervention group and the control group to reach full feeds, a sample size of 52 in each arm is required. The investigators expect to recruit 104 infants in less than 2 years based on current admission rates. With an additional 20% for replacements, a total of 124 infants or 248 infant-mother pairs.
Subjects will participate in the study until hospital discharge.
Outcome Measures: The primary objective of this study is to evaluate if early feeding started at 6 hours of age shortens the time to attain full feeds in the first 30 days of life when compared to starting feeds based on current ROH standard protocol.
Secondary outcomes to be assessed from date of randomization until the date of discharge or date of death from any cause, whichever came first, assessed up to 20 weeks of age will include:
- Days to goal enteral feeds (days)
- Days of central line use (days)
- Days of TPN use (days)
- Number of feeding intolerance events(feedings held for \>24 hours per clinician judgment due to gastrointestinal symptoms such as emesis, abdominal distention, etc.) (N)
- Time to regain birth weight) (days)
- anthropometric parameters at birth, at 1500 g weight mark, at 36 weeks postmenstrual age, and at discharge: weight (grams), length (cm), and head circumference (cm)
- Bronchopulmonary dysplasia development assessed at 36 weeks postmenstrual age (Y/N)
- IVH grade (I to IV) assessed at 2 weeks and 4 weeks of age (severe defined as Grade III and Grade IV (Y/N))
- Days on antibiotics (days) during the entire hospitalization from birth until discharge
- Length of NICU stay (days) from birth until discharge
- The presence of a patent ductus arteriosus incidence requiring treatment anytime from birth until discharge (Y/N)
10- Necrotizing enterocolitis incidence requiring treatment anytime from birth until discharge (Y/N) 11- Catheter-related infections anytime from birth until discharge (Y/N) 10- Death incidence (Y/N) 12-Number of subjects not consented and the reason from the study\'s first enrollment date until study closure.
- Conditions
- Extra Uterine Growth Restriction, Premature Infant Disease, VLBW - Very Low Birth Weight Infant
- Being tested
- Starting feeds within 6 hours of life, Standard feeding protocol
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Starting feeds within 6 hours of lifeOther
Starting feeds within 6 hours of life
Standard feeding protocolOther
Starting feeds based on standard protocol as per primary team
| Study group | Role | What they receive |
|---|---|---|
| Early feeding arm | Experimental | Not described Receives: Other: Starting feeds within 6 hours of life |
| Control arm | Active comparator | Not described Receives: Other: Standard feeding protocol |
What is being measured
The primary outcome is the main question the study is designed to answer.
Day of life reaching full feeds
The primary outcome is the age in days in the first 30 days of life when the infant reaches full feeds.
Measured: From birth until day of life full feeds reached in the first 30 days of life
Secondary outcomes (11)
Secondary Outcomes
Days of central line use (Days)
Measured: From birth until hospital discharge
Secondary Outcomes
Days of TPN use (Days)
Measured: From birth until hospital discharge
Secondary Outcomes
The number of feeding intolerance events defined as feedings held for \>24 hours per clinician judgment due to gastrointestinal symptoms such as emesis, abdominal distention, etc.
Measured: From birth until 30 days of life
Secondary Outcomes
The development of BPD (Y/N)
Measured: From birth until hospital discharge
Secondary Outcomes
The development of IVH (Y/N)
Measured: From birth until hospital discharge
Secondary Outcomes
Days of antibiotic use (Days)
Measured: From birth until hospital discharge
Secondary Outcomes
Length of NICU stay (Days)
Measured: From birth until hospital discharge
Secondary Outcomes
PDA incidence requiring treatment (Y/N)
Measured: From birth until hospital discharge
Secondary Outcomes
The development of CLABSI (Y/N)
Measured: From birth until hospital discharge
Secondary Outcomes
The development of Death (Y/N)
Measured: From birth until hospital discharge
Secondary Outcomes
The development of NEC (Y/N)
Measured: From birth until hospital discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Dec 2024
- Study start1 Jun 2024
- Primary completion30 Jun 2026 (estimated)
- Study completion30 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Extra Uterine Growth RestrictionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 248 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Tennessee
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Mohamad Elabiad, MD, Principal investigator, UTHSC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06731439
- Sponsor's protocol ID
- 24-09828-FB
- Status last verified
- Dec 2024
- First submitted
- 22 Jul 2024
- Last updated
- 12 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Parker LA, Desorcy-Scherer K, Magalhaes M. Feeding Strategies in Preterm Very Low Birth-Weight Infants: State-of-the-Science Review. Adv Neonatal Care. 2021 Dec 1;21(6):493-502. doi: 10.1097/ANC.0000000000000849.
PubMed 33675303Walsh V, Brown JVE, Copperthwaite BR, Oddie SJ, McGuire W. Early full enteral feeding for preterm or low birth weight infants. Cochrane Database Syst Rev. 2020 Dec 27;12(12):CD013542. doi: 10.1002/14651858.CD013542.pub2.
PubMed 33368149Morgan J, Bombell S, McGuire W. Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD000504. doi: 10.1002/14651858.CD000504.pub4.
PubMed 23543508Gao L, Shen W, Wu F, Mao J, Liu L, Chang YM, Zhang R, Ye XZ, Qiu YP, Ma L, Cheng R, Wu H, Chen DM, Chen L, Xu P, Mei H, Wang SN, Xu FL, Ju R, Zheng Z, Lin XZ, Tong XM; Chinese Multicenter EUGR Collaborative Group. Effect of early initiation of enteral nutrition on short-term clinical outcomes of very premature infants: A national multicenter cohort study in China. Nutrition. 2023 Mar;107:111912. doi: 10.1016/j.nut.2022.111912. Epub 2022 Nov 12.
PubMed 36577163
Study at a glance
From the registry record, last updated by the sponsor on 12 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
- ClinicalTrials.gov ID
- NCT06731439
- Acronym / sponsor ID
- 24-09828-FB
- Conditions
- Extra Uterine Growth Restriction, Premature Infant Disease, VLBW - Very Low Birth Weight Infant
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 248 participants (estimated)
- Lead sponsor
- University of TennesseeUniversity, hospital or other
- Study start
- 1 Jun 2024 (actual)
- Primary completion
- 30 Jun 2026 (estimated)
- Study completion
- 30 Jun 2027 (estimated)
- First posted
- 12 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Feeding advancements in ELBW infants have evolved over decades. The fear of causing mortality and morbidity, notably NEC, have made providers cautious when advancing feeds. ELBW infants initially remained NPO for several days before initiating trophic feeds. However, data then showed that there was no increase in mortality and morbidity if trophic feeds were initiated earlier. Then data showed that a short duration of trophic feeds did not increase mortality and morbidity when compared to a prolonged duration. More recent data showed that enteral feeding should be initiated early, preferably within 24 hours of birth, because it may promote feeding tolerance, shorten the time to reach total enteral feeding, and reduce the incidence of extrauterine growth restriction and late onset sepsis without increasing the risk of developing NEC. The management of enteral nutrition in ELBW infants is still very variable. For example, there is no consensus on the optimal time point after birth at which enteral nutrition can be started. This study evaluates the benefits of starting feeds by 6 hours of life Purpose: The primary aim of this study is to evaluate if in infants ≤ 1000g birth weight, is there a benefit initiating feeds by 6 hours of life (compared to current feeding practice data of 3 days of life) on decreasing the time to attain full feeds in the first 30 days of life. The secondary aim is to evaluate if antenatal feeding discussions would streamline feeding management post-delivery.
Detailed description
Rationale: Although current evidence supports initiating enteral feedings as early as the first day of life in extremely low birth weight infants, there are two main barriers that are usually associated with the initiation of feeding not taking place until an average of the third day of life. Since it is common to supplement the infant's nutrition with donor breast milk, and since donor breast milk requires parental consent, the process of consenting is usually done after the infant is born. This would be the time when the parents are updated with the status of their child and the time when other consents are taken. For example, this would be the time to talk about and take consent for blood transfusions, central line placement, and donor breast milk supplementing the infant's nutrition. The mother is the one most commonly giving consent. In situations after cesarean section or after receiving pain medications, the mother is not in a state where she can be approached for consent. This is typically not an issue for interventions like blood transfusions and central line insertions as the need does not arise typically until after a few days. However, when it comes to enteral feeding, it is recommended to start feeding as early as possible. However, because of the previously listed reasons, this sometimes gets pushed further until the mother is in a more stable situation to approach her for consent.
Another important aspect of feeding pertains to what is considered feeding and what is considered gut priming. It is generally considered that enteral feedings of 10 ml/kg/day are not enough volume to be considered "feeding." This volume is considered more of gut priming that stimulates gut enzymes to get produced and starts the clock for the eventual advancement of feeds. For these initial 10 ml/kg/day volume feeds, the term minimal enteral nutrition has been commonly used. In patients to be enrolled in this study, this will come out to be an average of 0.75 ml every 3 hours, a volume that is typically less than the volume of gastric juice being internally produced by the infant. It is also a volume so small that it is not thought to lead to any significant negative sequelae.
On the other hand, research has shown that prolonged enteral fasting may diminish the functional adaptation of the immature gastrointestinal tract and extend the need for parenteral nutrition along with its risk of sepsis-related morbidity and mortality. Research has also shown that the initiation of early enteral feeds could release trophic endogenous agents and inhibit the release of inflammatory mediators and cytokines. It also assists with the development of the intestinal mucosa, activates digestive enzymes, and improves digestion and absorption to avoid the complications associated with vascular catheterization, sepsis, long-term fasting, and vascular alimentation.
There are no uniform guidelines of how fast to advance feeds in this premature infant population. Depending on the practice, it may take a premature infant 7-15 days to reach the 150 ml/kg/day target volume.
Starting feeds by 6 hours is expected to initiate the feeding process for premature infants and be associated with several benefits. The aim of this study is to investigate if finalizing nutritional care plans with the mother antenatally offers any clinically beneficial outcomes in either streamlining the nutritional care plan as a short-term outcome or being associated with beneficial long-term outcomes. This is currently not practiced because either there is not enough personnel or it is felt not of a high yield because the mother may not end up delivering and come back at another visit to deliver. The study would leverage that starting feeds by 6 hours of life is not considered unsafe because the volume of milk that would be given every 3 hours is \<1ml. However, starting early would have helped the infant start the feeding advancement process. The focus is more on "starting" than on "feeding" since the volume received in the first 24 hours is not considered food as much as it is considered gut priming. In other words, the treatment arm group that will have their feeds started by 6 hours of age will have the benefit of having their nutrition clock started earlier when compared to the current standard of care.
Study Project Population:
Infants will be eligible for the study if they have a birth weight ≤1000g and are born in the Regional One Health neonatal intensive care unit in Memphis, TN, during study enrollment. In addition, the clinical care team at the time of enrollment must agree with the neonate\'s participation. Infants found to have congenital malformations, congenital gastrointestinal obstructions, on more than one pressor, or on dopamine \> 5 mcg/kg/min will be excluded. Infants clinically progressing towards imminent death will also be excluded. The mothers of these infants will also be included as part of the study population as the investigators will be collecting maternal health information as it directly affects the neonates.
Research Design:
This will be a prospective randomized controlled trial. The study will be unblinded and conducted at Regional One Health. The target population will be infants with a birth weight of ≤1000g. After informed consent is obtained from parents and after birth but before 6 hours of life, infants meeting the criteria will be randomized to one of two arms: early feeding (intervention group) or standard protocol feeding (control group). In the intervention group, feeds of expressed breast milk, donor breast milk, or formula will be initiated within 6 hours of life based on the mother\'s feeding preference obtained during the antenatal consent. Feeds will be advanced daily (10 ml/kg/day in the \<750g birth weight group and 15 ml/kg/day in the 751-1000g birth weight group) and managed by the primary care team based on their assessment. In the control group, the primary care team will start feedings based on the current protocol. This includes not advancing for the first three days after feeding initiation for infants weighing \< 750g per current feeding protocol. If randomized to the control group, all feeding management initiation, advancement, and obtaining consent for donor breast milk will be done by the primary care team. This step is important as it helps to evaluate if antenatal feeding discussions would streamline feeding management post-delivery.
Study Project/Procedure: The growth indices , including height (cm), weight (g), head circumference (cm), and calculated BMI (kg/m2), will be performed weekly as part of our unit\'s standard practice for all infants admitted. Patient data will be collected from medical records at regular intervals during the study. The primary medical team will manage all medical and feeding-related decisions. The maternal data that the investigators will be collecting for this study from the mother\'s chart is information such as age, BMI, medications used during pregnancy, medical problems such as diabetes or high blood pressure, and other information that could directly influence the neonate. Milk fortification will take place when feeding volumes reach 40 ml/kg/d. All patients will have feedings temporarily stopped during blood transfusions as per unit guidelines. The primary team can decide on feeding advancement if they plan to administer more than 48 hours of antibiotics. The volume used to start the feeding is not large enough to likely be associated with any feeding intolerance. In both the treatment and control groups, if the primary team decides that the infant is not tolerating feeding, then standard clinical interventions are applicable. These could range from decreasing the volume of feeding to a lower volume or even stopping the feeds completely. Feeding intolerance is not uncommon in this population and both interventions of either decreasing the volume or stopping the feeding are also common interventions. If feeding advancements are paused or feedings are stopped altogether, the primary team will be asked to document their concerns and reasons why feedings are paused or stopped. This will be evaluated every 12 hours.
At a Power=80%, α=5%, and to detect a mean difference of 4(±5) days between the early feeding intervention group and the control group to reach full feeds, a sample size of 52 in each arm is required. The investigators expect to recruit 104 infants in less than 2 years based on current admission rates. With an additional 20% for replacements, a total of 124 infants or 248 infant-mother pairs.
Subjects will participate in the study until hospital discharge.
Outcome Measures: The primary objective of this study is to evaluate if early feeding started at 6 hours of age shortens the time to attain full feeds in the first 30 days of life when compared to starting feeds based on current ROH standard protocol.
Secondary outcomes to be assessed from date of randomization until the date of discharge or date of death from any cause, whichever came first, assessed up to 20 weeks of age will include:
- Days to goal enteral feeds (days)
- Days of central line use (days)
- Days of TPN use (days)
- Number of feeding intolerance events(feedings held for \>24 hours per clinician judgment due to gastrointestinal symptoms such as emesis, abdominal distention, etc.) (N)
- Time to regain birth weight) (days)
- anthropometric parameters at birth, at 1500 g weight mark, at 36 weeks postmenstrual age, and at discharge: weight (grams), length (cm), and head circumference (cm)
- Bronchopulmonary dysplasia development assessed at 36 weeks postmenstrual age (Y/N)
- IVH grade (I to IV) assessed at 2 weeks and 4 weeks of age (severe defined as Grade III and Grade IV (Y/N))
- Days on antibiotics (days) during the entire hospitalization from birth until discharge
- Length of NICU stay (days) from birth until discharge
- The presence of a patent ductus arteriosus incidence requiring treatment anytime from birth until discharge (Y/N)
10- Necrotizing enterocolitis incidence requiring treatment anytime from birth until discharge (Y/N) 11- Catheter-related infections anytime from birth until discharge (Y/N) 10- Death incidence (Y/N) 12-Number of subjects not consented and the reason from the study\'s first enrollment date until study closure.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Early feeding arm | Experimental | Other: Starting feeds within 6 hours of life |
| Control arm | Active comparator | Other: Standard feeding protocol |
Who may qualify
- Ages
- 1 minute to 6 hours
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- All infants less than or equal to 1000 g
- Clinical care team in agreement with patient's participation
- All mothers with pregnancies with EFW close to 1000g or less.
Key exclusion criteria (7 listed)
- 1 congenital malformations that may affect gastro intestinal perfusion
- 2 Clinically progressing towards imminent death
- 3 congenital gastrointestinal obstructions
- 4 Mothers unlikely to deliver infants ≤ 1000g
- 5 Infant on pressors other than dopamine given at < 5mcg/kg/min. Dopamine is an exclusion if administered at a dose exceeding 5mcg/kg/min.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Starting feeds within 6 hours of lifeStarting feeds within 6 hours of life | Other | Early feeding arm |
| Standard feeding protocolStarting feeds based on standard protocol as per primary team | Other | Control arm |
Primary outcome
Day of life reaching full feeds
Time frame: From birth until day of life full feeds reached in the first 30 days of life
The primary outcome is the age in days in the first 30 days of life when the infant reaches full feeds.
11 secondary outcomes
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until 30 days of life
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until hospital discharge
Secondary Outcomes
Time frame: From birth until hospital discharge
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Dec 2024.
- Background: PubMed 33675303Parker LA, Desorcy-Scherer K, Magalhaes M. Feeding Strategies in Preterm Very Low Birth-Weight Infants: State-of-the-Science Review. Adv Neonatal Care. 2021 Dec 1;21(6):493-502. doi: 10.1097/ANC.0000000000000849.
- Background: PubMed 33368149Walsh V, Brown JVE, Copperthwaite BR, Oddie SJ, McGuire W. Early full enteral feeding for preterm or low birth weight infants. Cochrane Database Syst Rev. 2020 Dec 27;12(12):CD013542. doi: 10.1002/14651858.CD013542.pub2.
- Background: PubMed 23543508Morgan J, Bombell S, McGuire W. Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD000504. doi: 10.1002/14651858.CD000504.pub4.
- Background: PubMed 36577163Gao L, Shen W, Wu F, Mao J, Liu L, Chang YM, Zhang R, Ye XZ, Qiu YP, Ma L, Cheng R, Wu H, Chen DM, Chen L, Xu P, Mei H, Wang SN, Xu FL, Ju R, Zheng Z, Lin XZ, Tong XM; Chinese Multicenter EUGR Collaborative Group. Effect of early initiation of enteral nutrition on short-term clinical outcomes of very premature infants: A national multicenter cohort study in China. Nutrition. 2023 Mar;107:111912. doi: 10.1016/j.nut.2022.111912. Epub 2022 Nov 12.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mohamad Elabiad, MD principal investigator
UTHSC
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Starting feeds within 6 hours of life and Standard feeding protocol in people with Extra Uterine Growth Restriction and Premature Infant Disease, run by University of Tennessee at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mohamad Elabiad, MD (901-448-4751, Melabiad@uthsc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Day of life reaching full feeds (time frame: From birth until day of life full feeds reached in the first 30 days of life). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06731439, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2024.